Cushman & Wakefield plc Quarterly Costs and Expenses in USD from Q2 2017 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Total costs of sales and operating expenses for the period.
Summary
Cushman & Wakefield plc quarterly/annual Costs and Expenses history and growth rate from Q2 2017 to Q3 2024.
  • Cushman & Wakefield plc Costs and Expenses for the quarter ending September 30, 2024 was $2.27B, a 1.82% increase year-over-year.
  • Cushman & Wakefield plc Costs and Expenses for the twelve months ending September 30, 2024 was $9.1B, a 3.06% decline year-over-year.
  • Cushman & Wakefield plc annual Costs and Expenses for 2023 was $9.29B, a 2.95% decline from 2022.
  • Cushman & Wakefield plc annual Costs and Expenses for 2022 was $9.57B, a 7.64% increase from 2021.
  • Cushman & Wakefield plc annual Costs and Expenses for 2021 was $8.89B, a 12.6% increase from 2020.
Costs and Expenses, Trailing 12 Months (USD)
Costs and Expenses, Quarterly (USD)
Costs and Expenses, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 $9.1B $2.27B +$40.6M +1.82% Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-05
Q2 2024 $9.05B $2.22B -$132M -5.62% Apr 1, 2024 Jun 30, 2024 10-Q 2024-07-30
Q1 2024 $9.19B $2.17B -$102M -4.48% Jan 1, 2024 Mar 31, 2024 10-Q 2024-04-30
Q4 2023 $9.29B $2.44B -$93.5M -3.69% Oct 1, 2023 Dec 31, 2023 10-K 2024-02-21
Q3 2023 $9.38B $2.23B -$175M -7.27% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $9.56B $2.35B -$86.3M -3.54% Apr 1, 2023 Jun 30, 2023 10-Q 2024-07-30
Q1 2023 $9.64B $2.27B +$71.9M +3.28% Jan 1, 2023 Mar 31, 2023 10-Q 2024-04-30
Q4 2022 $9.57B $2.54B -$98.4M -3.74% Oct 1, 2022 Dec 31, 2022 10-K 2024-02-21
Q3 2022 $9.67B $2.4B +$200M +9.1% Jul 1, 2022 Sep 30, 2022 10-Q 2023-10-31
Q2 2022 $9.47B $2.44B +$312M +14.7% Apr 1, 2022 Jun 30, 2022 10-Q 2023-08-01
Q1 2022 $9.16B $2.2B +$265M +13.7% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-05
Q4 2021 $8.89B $2.63B +$457M +21% Oct 1, 2021 Dec 31, 2021 10-K 2024-02-21
Q3 2021 $8.44B $2.2B +$271M +14% Jul 1, 2021 Sep 30, 2021 10-Q 2022-11-04
Q2 2021 $8.16B $2.12B +$317M +17.6% Apr 1, 2021 Jun 30, 2021 10-Q 2022-08-05
Q1 2021 $7.85B $1.93B -$49.9M -2.52% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-06
Q4 2020 $7.9B $2.18B -$307M -12.3% Oct 1, 2020 Dec 31, 2020 10-K 2023-02-24
Q3 2020 $8.2B $1.93B -$150M -7.2% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 $8.35B $1.81B -$262M -12.7% Apr 1, 2020 Jun 30, 2020 10-Q 2021-08-06
Q1 2020 $8.62B $1.98B +$51.9M +2.69% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $8.56B $2.48B +$126M +5.33% Oct 1, 2019 Dec 31, 2019 10-K 2022-02-25
Q3 2019 $8.44B $2.08B +$26.4M +1.28% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $8.41B $2.07B +$125M +6.43% Apr 1, 2019 Jun 30, 2019 10-Q 2020-08-07
Q1 2019 $8.29B $1.93B +$79.4M +4.29% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-08
Q4 2018 $8.21B $2.36B Oct 1, 2018 Dec 31, 2018 10-K 2021-02-26
Q3 2018 $2.06B +$292M +16.5% Jul 1, 2018 Sep 30, 2018 10-Q 2019-11-06
Q2 2018 $1.94B +$207M +11.9% Apr 1, 2018 Jun 30, 2018 10-Q 2019-08-02
Q1 2018 $1.85B Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-08
Q3 2017 $1.76B Jul 1, 2017 Sep 30, 2017 10-Q 2018-11-14
Q2 2017 $1.74B Apr 1, 2017 Jun 30, 2017 10-Q 2018-09-06
* An asterisk sign (*) next to the value indicates that the value is likely invalid.